SCHEMBL26645283

SCHEMBL26645283

CC(C)(C)OC(=O)N1CCn2nc(-c3ccc(Cl)cc3CO)c(-c3ccncc3)c2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 2/20 0.40
▸ CSNK1E P49674 2/20 0.40
▸ DPP4 P27487 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SUV39H2 Q9H5I1 5/20 0.38
▸ CYP3A4 P08684 2/20 0.37
▸ CYP3A5 P20815 2/20 0.37
▸ GPR119 Q8TDV5 3/20 0.36
▸ RORC P51449 1/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ SLC6A15 Q9H2J7 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CACNB4 O00305 1/20 0.35
▸ CACNA1A O00555 1/20 0.35
▸ CACNA1G O43497 1/20 0.35
▸ CACNG3 O60359 1/20 0.35
▸ CACNA1F O60840 1/20 0.35
▸ CACNA1H O95180 1/20 0.35
▸ CACNB3 P54284 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645207 0.89 CSNK1D (0.42) CSNK1DCSNK1EDPP4MEN1KMT2A
SCHEMBL26645116 0.88 CYP3A4 (0.45) CSNK1DCSNK1EDPP4MEN1KMT2A
SCHEMBL30622820 0.87 CYP3A4 (0.43) CSNK1DCSNK1EMEN1KMT2ACYP3A4
SCHEMBL26645098 0.87 CYP3A4 (0.43) CSNK1DCSNK1EMEN1KMT2ACYP3A4
SCHEMBL26645019 0.85 CSNK1D (0.47) CSNK1DCSNK1EMEN1KMT2ACYP3A4
SCHEMBL26644887 0.84 CSNK1E (0.36) CSNK1DCSNK1E
SCHEMBL30622922 0.84 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2ACYP3A4
SCHEMBL26645443 0.84 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2ACYP3A4
SCHEMBL26645619 0.83 CSNK1D (0.44) CSNK1DCSNK1EMEN1KMT2AGPR119
SCHEMBL30623074 0.82 CSNK1E (0.41) CSNK1DCSNK1ECYP3A4CYP3A5RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback